314 related articles for article (PubMed ID: 36790767)
1. Management of Hepatocellular Carcinoma: A Review.
Brown ZJ; Tsilimigras DI; Ruff SM; Mohseni A; Kamel IR; Cloyd JM; Pawlik TM
JAMA Surg; 2023 Apr; 158(4):410-420. PubMed ID: 36790767
[TBL] [Abstract][Full Text] [Related]
2. The diagnosis and treatment of hepatocellular carcinoma.
Hartke J; Johnson M; Ghabril M
Semin Diagn Pathol; 2017 Mar; 34(2):153-159. PubMed ID: 28108047
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic and therapeutic management of hepatocellular carcinoma.
Bellissimo F; Pinzone MR; Cacopardo B; Nunnari G
World J Gastroenterol; 2015 Nov; 21(42):12003-21. PubMed ID: 26576088
[TBL] [Abstract][Full Text] [Related]
4. Asian consensus workshop report: expert consensus guideline for the management of intermediate and advanced hepatocellular carcinoma in Asia.
Han KH; Kudo M; Ye SL; Choi JY; Poon RT; Seong J; Park JW; Ichida T; Chung JW; Chow P; Cheng AL
Oncology; 2011; 81 Suppl 1():158-64. PubMed ID: 22212951
[TBL] [Abstract][Full Text] [Related]
5. Locoregional therapies for hepatocellular carcinoma: a critical review from the surgeon's perspective.
Poon RT; Fan ST; Tsang FH; Wong J
Ann Surg; 2002 Apr; 235(4):466-86. PubMed ID: 11923602
[TBL] [Abstract][Full Text] [Related]
6. Goals and targets for personalized therapy for HCC.
Couri T; Pillai A
Hepatol Int; 2019 Mar; 13(2):125-137. PubMed ID: 30600478
[TBL] [Abstract][Full Text] [Related]
7. A Review and Update of Treatment Options and Controversies in the Management of Hepatocellular Carcinoma.
Dhir M; Melin AA; Douaiher J; Lin C; Zhen WK; Hussain SM; Geschwind JF; Doyle MB; Abou-Alfa GK; Are C
Ann Surg; 2016 Jun; 263(6):1112-25. PubMed ID: 26813914
[TBL] [Abstract][Full Text] [Related]
8. From diagnosis to treatment of hepatocellular carcinoma: An epidemic problem for both developed and developing world.
Dimitroulis D; Damaskos C; Valsami S; Davakis S; Garmpis N; Spartalis E; Athanasiou A; Moris D; Sakellariou S; Kykalos S; Tsourouflis G; Garmpi A; Delladetsima I; Kontzoglou K; Kouraklis G
World J Gastroenterol; 2017 Aug; 23(29):5282-5294. PubMed ID: 28839428
[TBL] [Abstract][Full Text] [Related]
9. Hepatobiliary Cancers, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology.
Benson AB; D'Angelica MI; Abbott DE; Anaya DA; Anders R; Are C; Bachini M; Borad M; Brown D; Burgoyne A; Chahal P; Chang DT; Cloyd J; Covey AM; Glazer ES; Goyal L; Hawkins WG; Iyer R; Jacob R; Kelley RK; Kim R; Levine M; Palta M; Park JO; Raman S; Reddy S; Sahai V; Schefter T; Singh G; Stein S; Vauthey JN; Venook AP; Yopp A; McMillian NR; Hochstetler C; Darlow SD
J Natl Compr Canc Netw; 2021 May; 19(5):541-565. PubMed ID: 34030131
[TBL] [Abstract][Full Text] [Related]
10. Yttrium-90 microsphere radioembolisation for unresectable hepatocellular carcinoma.
Abdel-Rahman OM; Elsayed Z
Cochrane Database Syst Rev; 2016 Feb; 2():CD011313. PubMed ID: 26905230
[TBL] [Abstract][Full Text] [Related]
11. New concepts in the treatment of hepatocellular carcinoma.
Sidali S; Trépo E; Sutter O; Nault JC
United European Gastroenterol J; 2022 Sep; 10(7):765-774. PubMed ID: 35975347
[TBL] [Abstract][Full Text] [Related]
12. Review article: the management of hepatocellular carcinoma.
Cabrera R; Nelson DR
Aliment Pharmacol Ther; 2010 Feb; 31(4):461-76. PubMed ID: 19925500
[TBL] [Abstract][Full Text] [Related]
13. AGA Clinical Practice Update on Screening and Surveillance for Hepatocellular Carcinoma in Patients With Nonalcoholic Fatty Liver Disease: Expert Review.
Loomba R; Lim JK; Patton H; El-Serag HB
Gastroenterology; 2020 May; 158(6):1822-1830. PubMed ID: 32006545
[TBL] [Abstract][Full Text] [Related]
14. Multidisciplinary strategies to improve treatment outcomes in hepatocellular carcinoma: a European perspective.
Colombo M; Raoul JL; Lencioni R; Galle PR; Zucman-Rossi J; Bañares R; Seehofer D; Neuhaus P; Johnson P
Eur J Gastroenterol Hepatol; 2013 Jun; 25(6):639-51. PubMed ID: 23628963
[TBL] [Abstract][Full Text] [Related]
15. Prospective evaluation of patients with early-/intermediate-stage hepatocellular carcinoma with disease progression following arterial locoregional therapy: candidacy for systemic treatment or clinical trials.
Memon K; Kulik L; Lewandowski RJ; Gupta R; Ryu RK; Miller FH; Vouche M; Atassi R; Ganger D; Mulcahy MF; Salem R
J Vasc Interv Radiol; 2013 Aug; 24(8):1189-1197.e2. PubMed ID: 23474327
[TBL] [Abstract][Full Text] [Related]
16. Multidisciplinary management of hepatocellular carcinoma: where are we today?
Marrero JA
Semin Liver Dis; 2013 Feb; 33 Suppl 1():S3-10. PubMed ID: 23457037
[TBL] [Abstract][Full Text] [Related]
17. Multimodal treatment of hepatocellular carcinoma on cirrhosis: an update.
Vivarelli M; Montalti R; Risaliti A
World J Gastroenterol; 2013 Nov; 19(42):7316-26. PubMed ID: 24259963
[TBL] [Abstract][Full Text] [Related]
18. Current management of hepatocellular carcinoma.
Tabrizian P; Roayaie S; Schwartz ME
World J Gastroenterol; 2014 Aug; 20(30):10223-37. PubMed ID: 25132740
[TBL] [Abstract][Full Text] [Related]
19. Current trends and recent advances in diagnosis, therapy, and prevention of hepatocellular carcinoma.
Wang CH; Wey KC; Mo LR; Chang KK; Lin RC; Kuo JJ
Asian Pac J Cancer Prev; 2015; 16(9):3595-604. PubMed ID: 25987009
[TBL] [Abstract][Full Text] [Related]
20. Established and emerging therapies for hepatocellular carcinoma.
Cicinnati VR; Sotiropoulos GC; Beckebaum S
Minerva Med; 2010 Dec; 101(6):405-18. PubMed ID: 21196900
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
